ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiologic methods"

  • Abstract Number: 032 • 2020 Pediatric Rheumatology Symposium

    The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus

    Joyce Chang1, Alaina Davis 2, Marisa Klein-Gitelman 3, Zuleyha Cidav 4, David Mandell 5 and Andrea Knight 6, 1Children's Hospital of Philadelphia, Philadelphia, 2Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee, 3Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, 4University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, 5Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 6SickKids Research Institute, Toronto, Canada

    Background/Purpose: Youth with systemic lupus erythematosus (SLE) experience significant health care burden and high rates of psychiatric disorders. Optimizing medication adherence is critical for preventing…
  • Abstract Number: 058 • 2020 Pediatric Rheumatology Symposium

    Kawasaki Disease in Ontario Children from 1995-2017: A Population-based Descriptive Analysis

    Cal Robinson 1, Rahul Chanchlani 1, Megan Schlorff 1, Francis Lao 1, Tapas Mondal 1, Catherine Demers 1, Elizabeth Darling 1, Sandeep Brar 2, Rulan Parekh 3, Hsien Seow 1, Eric Benchimol 4 and Michelle Batthish1, 1McMaster University, Hamilton, Canada, 2University of California, San Fransisco, 3University of Toronto, Toronto, Canada, 4University of Ottawa, Ottawa, Canada

    Background/Purpose: Kawasaki disease (KD) is a childhood vasculitis with rising global incidence and the most common cause of childhood acquired heart disease in the developed…
  • Abstract Number: 103 • 2020 Pediatric Rheumatology Symposium

    Unexpectedly High Incidence of Kawasaki Disease in a Well-Characterized Population in Atlantic Canada

    Abdulrahman Alkanhal1, Joseph , Saunders 2, Fajer Altammar 3, Adam Huber 4, Andrew Lynk 2, Alison MacLeod 5, Oliva Ortiz-Alvarez 6, Meighan Adams 2, Suzanne Ramsey 7, Elizabeth Stringer 7, Andrew Warren 2 and Bianca Lang 8, 1University of Alberta, Edmonton, Alberta, Canada, 2Dalhousie University, Halifax, Canada, 3Mcmaster University, Hamilton, Canada, 4IWK Health Centre & Dalhousie University, Halifax, Nova Scotia, Canada, 5Annapolis Valley Health, Kentville, Canada, 6St Martha's Regional Hospital, Antigonish, Canada, 7IWK Health Centre, Halifax, Canada, 8Dalhousie University - Halifax, Halifax, Canada

    Background/Purpose: Kawasaki Disease (KD), a systemic vasculitis of unknown etiology, is now the leading cause of acquired heart disease in children in North America. Its…
  • Abstract Number: 2313 • 2019 ACR/ARP Annual Meeting

    Patients with Rheumatoid Arthritis Have a Higher Risk of Bipolar Disorder: A Systematic Review and Meta-analysis

    Patompong Ungprasert1, Nipith Charoenngam 2 and Ben Ponvilawan 2, 1Cleveland Clinic, Cleveland, OH, Bangkok, Thailand, 2Mahidol University, Bangkok, Thailand

    Background/Purpose: Patients with chronic autoimmune diseases may have a higher risk of psychiatric illness as a result of chronic neuro-inflammation and immune dysregulation. The current…
  • Abstract Number: 2715 • 2019 ACR/ARP Annual Meeting

    Incidence of Juvenile Idiopathic Arthritis in the United Kingdom: Estimates from a National Primary Care Dataset

    Ruth Costello1, Janet McDonagh 2, Will Dixon 1, Kimme Hyrich 2 and Jenny Humphreys 1, 1Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom, 2Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom / NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, Manchester, United Kingdom

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common childhood onset inflammatory arthritis.  The last estimates of incidence of this disease in the United Kingdom…
  • Abstract Number: 2824 • 2019 ACR/ARP Annual Meeting

    Antibiotic Use and the Development of Rheumatoid Arthritis (RA) and Risk of RA Flares: Case-Control and Self-Controlled Case Series Studies in Two National Electronic Patient Databases (SIDIAP and CPRD)

    Navraj Nagra1, Danielle Robinson 2, Antonella Delmestri 1, Stephanie Dakin 1, Sarah Snelling 1, Andrew Carr 1 and Daniel Prieto-Alhambra 1, 1University of Oxford, Oxford, United Kingdom, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

    Background/Purpose: The microbiome and specific bacterial triggers have been hypothesised to be involved in the pathogenesis of Rheumatoid Arthritis (RA) and RA flares. Antibiotic usage…
  • Abstract Number: 2822 • 2019 ACR/ARP Annual Meeting

    Depression and Subsequent Risk for Incident Seronegative Rheumatoid Arthritis Among Women

    Jeffrey Sparks1, Susan Malspeis 1, Jill Hahn 2, Andrea Roberts 2, Laura Kubzansky 2 and Karen Costenbader 1, 1Brigham and Women's Hospital, Boston, MA, 2Harvard School of Public Health, Boston, MA

    Background/Purpose: Depression is associated with elevated systemic inflammation and risk of several chronic diseases including lupus, psoriasis, and inflammatory bowel disease. However, the association between…
  • Abstract Number: 2826 • 2019 ACR/ARP Annual Meeting

    Risk of Serious Infections in Tofacitinib versus Other Biologic Drug Initiators in Patients with Rheumatoid Arthritis: A Multi-database Cohort Study

    Ajinkya Pawar 1, Rishi Desai 1, Nileesa Gautam 1 and Seoyoung C. Kim2, 1Brigham and Women's hospital, Boston, 2Brigham and Women’s Hospital and Harvard Medical School, Boston

    Background/Purpose: It is well-known that biologic or targeted synthetic DMARDs increase the risk of serious infections (SIs), but few studies have directly compared the risk…
  • Abstract Number: 179 • 2019 ACR/ARP Annual Meeting

    The Burden of Comorbidity in Patients with RA, PSA or SPA in a General Practice Registry

    Sofia Pazmino 1, Veerle Stouten 1, Patrick Verschueren 2, Pavlos Mamouris 1, Rene Westhovens 3, Kurt De Vlam 2, Delphine Bertrand 1, Kristien Van der Elst 2, Bert Vaes 1 and Diederik De Cock1, 1KU Leuven, Leuven, Belgium, 2University Hospital Leuven, Leuven, Belgium, 3University Hospitals, Leuven, Belgium

    Background/Purpose: Rheumatoid arthritis (RA), psoriatic arthritis (PSA) and spondyloarthritis (SPA) are the most common inflammatory rheumatic diseases, associated with a high burden of comorbidities and…
  • Abstract Number: 181 • 2019 ACR/ARP Annual Meeting

    Prevalence of Renal Impairment in a US Rheumatoid Arthritis Population

    Jon Giles1, Lee Simon 2, Janet Pope 3, Jim Paik 4, Michael Grabner 5, Amanda Quebe 6, Carol Gaich 6, Claudia Salinas 6 and Jeffrey Curtis 7, 1Division of Rheumatology, Columbia University, New York, NY, 2SDG LLC, Cambridge, 3Western University, London, ON, Canada, 4Eli Lilly & Company, Indianapolis, IN, 5HealthCore, Inc., Wilmington, DE, 6Eli Lilly and Company, Indianapolis, IN, 7University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Clinical management of rheumatoid arthritis (RA) must consider patient renal function, particularly for medications that rely on renal clearance and require dose adjustment or…
  • Abstract Number: 183 • 2019 ACR/ARP Annual Meeting

    Exploring Heterogeneity in Rheumatoid Arthritis: Patient Profiling Through Principal Component and Cluster Analysis of the BRASS Registry

    Jeffrey Curtis1, Michael Weinblatt 2, Kenneth Saag 1, Vivian Bykerk 3, Christina Charles-Schoeman 4, Stefano Fiore 5, Gregory St John 6, Toshio Kimura 7, Shen Zheng 5, Clifton Bingham 8, Grace Wright 9, Martin Bergman 10, Kamala Nola 11, Daniel Furst 4 and Nancy Shadick 2, 1University of Alabama at Birmingham, Birmingham, AL, 2Brigham and Women's Hospital, Boston, MA, 3Hospital for Special Surgery, New York City, NY, 4University of California, Los Angeles, CA, 5Sanofi Genzyme, Bridgewater, NJ, 6Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 7Regeneron Pharmaceuticals, Inc, Tarrytown, NY, 8Johns Hopkins University, Baltimore, MD, 9Private Practice, New York City, NY, 10Drexel University College of Medicine, Stockholm, Sweden, 11Lipscomb University College of Pharmacy & Health Sciences, Nashville, TN

    Background/Purpose: Data-driven principal component (PC) and cluster analysis has the potential to identify previously unknown patient subgroups within a rheumatoid arthritis (RA) registry to establish…
  • Abstract Number: 198 • 2019 ACR/ARP Annual Meeting

    Assessing Care Quality in Rheumatology Services

    Mark Yates1, Sam Norton 1, Alexander MacGregor 2, Katie Bechman 3, Sanketh Rampes 3 and James Galloway 4, 1Kings College London, London, 2University of East Anglia, Norwich, United Kingdom, 3King's College London, London, United Kingdom, 4Kings College London, London, United Kingdom

    Background/Purpose: There is high-quality evidence that prompt diagnosis and treatment have beneficial impact on outcomes in RA. Current guidelines from both North America and Europe…
  • Abstract Number: 352 • 2019 ACR/ARP Annual Meeting

    Primary Hyperparathyroidism Is Associated with a Higher Level of Serum Uric Acid: A Systematic Review and Meta-analysis

    Ben Ponvilawan 1, Nipith Charoenngam 1 and Patompong Ungprasert2, 1Mahidol University, Bangkok, Thailand, 2Cleveland Clinic, Cleveland, OH, Bangkok, Thailand

    Background/Purpose: Studies have suggested that primary hyperparathyroidism could be a risk factor for hyperuricemia although the results were inconsistent across the studies. This systematic review…
  • Abstract Number: 821 • 2019 ACR/ARP Annual Meeting

    Trends in Incidence and Prevalence of Osteoarthritis in the United Kingdom: Findings from the Clinical Practice Research Datalink (CPRD)

    Subhashisa Swain1, Aliya Sarmanova 2, Christian Mallen 3, Chang Fu Kuo 4, Carol Coupland 5 and Weiya Zhang 6, 1University of Nottingham, Nottingham, England, United Kingdom, 22. Bristol Medical School, Population Health Sciences, University of Bristol, UK, Bristol, England, United Kingdom, 3Research Institute for Primary Care and Health Sciences, Keele University, UK, Keele, United Kingdom, 44. Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan (Republic of China), 55. Division of Primary Care, School of Medicine, University of Nottingham, Nottingham, England, United Kingdom, 61. Academic Rheumatology, Division of Rheumatology, Orthopaedics and Dermatology, University of Nottingham, Nottingham, England, United Kingdom

    Background/Purpose: Osteoarthritis (OA) is by far the most common arthritis.(1) However,  its chronological trend in the United Kingdom (UK) is not known. We aimed to…
  • Abstract Number: 1278 • 2019 ACR/ARP Annual Meeting

    Inpatient Epidemiology of Dermatomyositis and Polymyositis in the United States

    Patompong Ungprasert1, Wisit Cheungpasitporn 2, Charat Thongprayoon 3, Karn Wijarnpreecha 4 and Paul Kroner 5, 1Cleveland Clinic, Cleveland, OH, Bangkok, Thailand, 2University of Mississippi Medical Center, Jackson, MS, 3Mayo Clinic Rochester, Rochester, MN, 4Mayo Clinic Florida, Jacksonville, FL, 5Mayo Clinic Florida, Jacksonville

    Background/Purpose: Dermatomyositis (DM) and polymyositis (PM), collectively known as idiopathic inflammatory myositis (IIM), are autoimmune disorders characterized by inflammation of skeletal muscle, especially in the…
  • 1
  • 2
  • 3
  • …
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology